Cure Stat Rx is a closed-door home infusion and specialty pharmacy providing the high-quality compounded and specialty medications you need—when and how you need them. With competitive prices, personalized service, and precise procedures, you can have a one-stop source, filling every prescription with care and precision.
Cure Stat Rx was founded with a mission—to expand and pioneer treatments for rare and chronic diseases. This important pursuit has led to our partnerships with many health providers, insurance carriers, and manufacturers who trust us as their specialized pharmacy of choice. We are skilled experts who can help you deliver the right care to patients, with customized compounds and therapies focused on Home Infusion, Oncology/Hematology, Nutrition & Hydration, and other Specialty medications.
Company Details
- Employees
- 9
- Founded
- -
- Address
- 6725 Mesa Ridge Road,
- Industry
- Pharmaceutical Manufacturing
- NAICS
-
Pharmaceutical and Medicine ManufacturingMedicinal and Botanical ManufacturingPharmaceutical Preparation ManufacturingIn-Vitro Diagnostic Substance ManufacturingBiological Product (except Diagnostic) Manufacturing
- Website
- curestatrx.com
- Keywords
- Infusion Therapies, Specialty Therapies, Oncology Therapies, Immunotherapies, Sterile Compounding, Non-Sterile Compounding, Fertility Treatments, Pediatric Compounding, Ophthalmic Compounding, Veterinary Compounding.
- HQ
- San Diego, California
Cure Stat Rx Questions
Cure Stat Rx's website is curestatrx.com
Cure Stat Rx's LinkedIn profile is https://www.linkedin.com/company/curestatrx
Cure Stat Rx has
9 employees.
View email and phone details for 9
employees at Cure Stat Rx.
Cure Stat Rx's industry is
Pharmaceutical Manufacturing
Cure Stat Rx's top competitors are
Outcomes®,
Deramed Specialty Pharmacy,
Curerx Incorporated,
Rxsense,
Mosaic Pharmacy Service,
Cure Rx Pharmacy,
Pharmacy Quality Alliance,
Expressmed Partners,
Medwatchers,
Eversana.
Cure Stat Rx's categories are Pharmaceutical Manufacturing
Cure Stat Rx's founding year is 2017
